Guru Ownership Trend
Guru Analysis for VYNE Therapeutics Inc. (VYNE)
VYNE Therapeutics Inc. (VYNE), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q1 2026, a total of 1 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $11,615.22.
Top institutional holders include Renaissance Technologies (RenTech).
Institutional sentiment is currently Bullish. This is evidenced by a $10,337 net inflow during the quarter.
Recent activity highlights Renaissance Technologies (RenTech) who opened a new position.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q1 2026)
Guru Consensus (Q1 2026)
FAQs for VYNE Therapeutics Inc. (VYNE)
Major holders include Renaissance Technologies (RenTech) ($10,337). According to the latest reported data, 1 tracked investment managers collectively hold approximately 17,300 shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $10,337, with 1 managers increasing positions and 0 managers reducing holdings.
No tracked managers reduced or fully exited their positions in VYNE during the most recent reporting period.
Yes, 1 managers opened new positions in VYNE, and 0 increased their existing holdings. The total reported buy value was $10,337.